Hansen Medical (HNSN) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities:
Net income (loss)	-46.21M
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on sale of intellectual property
Gain on settlement of litigation	0
Depreciation and amortization	1.03M
Stock-based compensation	2.76M
Loss on disposal of fixed assets	-36K
Unrealized (gains) losses on investments
Provision for doubtful accounts	49K
Loss on settlement of note receivable	0
Changes in operating assets and liabilities:
Accounts receivable	558K
Inventories	1.04M
Deferred cost of goods sold
Prepaids and other current assets	-127K
Other long-term assets	564K
Accounts payable	-1.87M
Accrued liabilities	-828K
Deferred revenue	486K
Deferred rent
Other long-term liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment	-357K
Proceeds from sales and maturities of short-term investments	36K
Purchase of investments
Proceeds from sale of intellectual property
Collection of note receivable
Net cash provided by investing activities
Cash flows from financing activities:
Repayments of loans payable	0
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of common stock options	3K
Proceeds from employee stock purchase plan	214K
Withholding taxes paid on vested restricted stock units
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents	-4.15M
Cash and cash equivalents at beginning of period	24.53M
Cash and cash equivalents at end of period	20.38M

Entities mentioned with HNSN